financetom
Business
financetom
/
Business
/
Kroger Reaches $110 Million Settlement With Kentucky to Resolve Opioid Claims
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Kroger Reaches $110 Million Settlement With Kentucky to Resolve Opioid Claims
Jan 9, 2025 11:03 AM

01:44 PM EST, 01/09/2025 (MT Newswires) -- Kroger ( KR ) has agreed to pay nearly $110 million to the state of Kentucky to settle claims it played a role in the deadly opioid epidemic, according to a copy of the settlement seen by MT Newswires Thursday.

Under the settlement agreement, the company will pay $43.4 million to the state plus $66.6 million, the amount that Kentucky would have received had it participated in the supermarket chain's broader deal with multiple states last year.

Kroger ( KR ) announced a $1.4 billion settlement last year to resolve similar claims by multiple states, counties, and Native American tribes.

Kroger ( KR ) did not immediately respond to a request for comment from MT Newswires.

Price: 58.90, Change: -0.24, Percent Change: -0.41

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
India's Serum looks beyond COVID with new vaccines for malaria, dengue
India's Serum looks beyond COVID with new vaccines for malaria, dengue
Mar 10, 2024
PUNE, India (Reuters) - The CEO of the world's biggest vaccine maker, Serum Institute of India, said the company has bolstered its manufacturing ahead of launches over the next few years of shots against diseases like malaria and dengue by repurposing facilities used to make COVID-19 immunizations. With COVID manufacturing scaled back as demand ebbs, the company is using those...
India's Serum looks beyond COVID with new vaccines for malaria, dengue
India's Serum looks beyond COVID with new vaccines for malaria, dengue
Mar 10, 2024
PUNE, India March 10 (Reuters) - The CEO of the world's biggest vaccine maker, Serum Institute of India, said the company has bolstered its manufacturing ahead of launches over the next few years of shots against diseases like malaria and dengue by repurposing facilities used to make COVID-19 immunizations. With COVID manufacturing scaled back as demand ebbs, the company is...
Dutch, German governments nearing deal on Tennet grid, Bloomberg reports
Dutch, German governments nearing deal on Tennet grid, Bloomberg reports
Mar 10, 2024
March 10 (Reuters) - Netherlands is closing in on a deal to sell Tennet Holding's power grid in Germany to the government in Berlin, Bloomberg News reported on Sunday citing to people familiar with the matter. ...
Aramco hikes dividend 30% to $98 billion despite drop in profit
Aramco hikes dividend 30% to $98 billion despite drop in profit
Mar 10, 2024
DUBAI (Reuters) -Saudi Arabia's state-owned oil giant Aramco boosted its dividend despite net profit falling 24.7% to $121.3 billion in 2023 on lower oil prices and volumes, showing the state's continued reliance on oil revenue as it seeks to diversify. The profit, down from $161.1 billion in 2022, was still the company's second-highest on record, Aramco said on Sunday as...
Copyright 2023-2026 - www.financetom.com All Rights Reserved